IBL HealthCare Limited (PSX:IBLHL)

Market Cap	6.41B
Revenue (ttm)	4.36B
Net Income (ttm)	218.20M
Shares Out	98.53M
EPS (ttm)	2.21
PE Ratio	29.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,440,782
Average Volume	2,156,064
Open	66.96
Previous Close	66.81
Day's Range	64.48 - 67.37
52-Week Range	24.35 - 85.82
Beta	0.55
RSI	51.50
Earnings Date	Feb 18, 2026

About IBL HealthCare

IBL HealthCare Limited engages in marketing, selling, and distribution of healthcare and pharmaceutical products in Pakistan. The company offers toddler, baby cereals, infant formulas, medical, lifestyle nutrition, and specialty nutrition products; hygiene and safety products; consumer health products; and vision care and pharma products. It also provides renal care products, such as hollow fiber dialyzer, tubing sets for hemodialysis, double lumen catheter kits, and disposable AV fistula needles; critical care and anesthesia products, such as ...

• Industry: Food & Drug Retailing
• Sector: Consumer Non-Cyclicals
• Founded: 1997
• Employees: 224
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: IBLHL

Financial Performance

In 2025, IBL HealthCare's revenue was 4.32 billion, an increase of 19.96% compared to the previous year's 3.60 billion. Earnings were 208.37 million, an increase of 2658.05%.